USSTOCK.TODAY
Market Closed Log in Sign up

Drugs Made In America Acquisition II Corp(DMII) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

DMII
DMII
Drugs Made In America Acquisition II Corp
At close Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$10.23
-0.02 ▼ -0.20%
Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$10.23
+0.00 +0.00%
Trading Range Resistance 10.26 Support 10.21 Holding Same lines for 8 days

AI-drawn chart patterns are for reference only.

Full metrics table

Index ⓘ -P/E ⓘ 36.96EPS (ttm) ⓘ 0.28Insider Own ⓘ 22.15%Shs Outstand ⓘ 63.7MPerf Week ⓘ -0.1%
Market Cap ⓘ 0.65BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 49.6MPerf Month ⓘ 0.39%
Enterprise Value ⓘ 0.65BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 74.8%Short Float ⓘ 0.2%Perf Quarter ⓘ 0.79%
Income ⓘ 0.02BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ -Short Ratio ⓘ 0.72Perf Half Y ⓘ 1.69%
Sales ⓘ 0.00BP/B ⓘ 1.3EPS next 5Y ⓘ -ROA ⓘ 3.47%Short Interest ⓘ 0.10MPerf YTD ⓘ 3.33%
Book/sh ⓘ 7.86P/C ⓘ 5430.47EPS past 3/5Y ⓘ -ROE ⓘ 3.6%52W High ⓘ -0.97% ($10.33)Perf Year ⓘ -
Cash/sh ⓘ 0P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ 3.53%52W Low ⓘ 3.75% ($9.86)Perf 3Y ⓘ -
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -Gross Margin ⓘ -Volatility(W/M) ⓘ 0.09% 0.09%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 0.01Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.22EPS Q/Q ⓘ 10457.14%Profit Margin ⓘ -RSI (14) ⓘ 56.34Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.22Sales Q/Q ⓘ -SMA20 ⓘ 0.08% ($10.22)Beta ⓘ -Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ -SMA50 ⓘ 0.35% ($10.19)Rel Volume ⓘ 3.6Prev Close ⓘ $10.25
Employees ⓘ 2LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ 1.56% ($10.07)Avg Volume(3M) ⓘ 0.14MPrice ⓘ $10.23
IPO ⓘ 2025/12/3Option/Short ⓘ No/YesTrades ⓘ 283Volume ⓘ 486,888Change ⓘ -0.2%
Company
DMII DMIIDrugs Made In America Acquisition II Corp | NASD | Shell Companies Deep dive

💊 Drugs Made in America Acquisition II (DMII) is a special purpose acquisition company (SPAC) launched with the pharmaceutical industry as its merger target. It operates under a blank-check structure, placing the funds raised through its IPO in a trust account while seeking a merger partner that is a pharmaceutical or biotech company with a proven business model.

Quote

Over the past 1 year, on the higher side

1% below its 1-year high.

Now $10.23
52w low$9.8652w high$10.33
52W Range79%
Volume ⓘ 486,888

Traded more than usual. That is 360% of its average volume.

Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.

Peer comparison Shell Companies

It ranks #547 of 1430 in the industry

Based on market cap of $652M.

FAQ

FAQ

DMII belongs to the Financial sector and operates in the Shell Companies industry.

The market cap of DMII is approximately $652M, ranking 2,819 within its sector.

DMII has a P/E ratio of approximately 37.0x, which can be used to assess its valuation relative to the Financial sector average.

DMII has recorded a 52-week high of $10.33 and a low of $9.86.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels